ATE381618T1 - Polypeptidhormon phosphatonin - Google Patents

Polypeptidhormon phosphatonin

Info

Publication number
ATE381618T1
ATE381618T1 AT00971403T AT00971403T ATE381618T1 AT E381618 T1 ATE381618 T1 AT E381618T1 AT 00971403 T AT00971403 T AT 00971403T AT 00971403 T AT00971403 T AT 00971403T AT E381618 T1 ATE381618 T1 AT E381618T1
Authority
AT
Austria
Prior art keywords
polypeptide hormone
phosphatonin
hormone phosphatonin
polypeptide
hormone
Prior art date
Application number
AT00971403T
Other languages
English (en)
Inventor
Peter Rowe
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9926424.4A external-priority patent/GB9926424D0/en
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of ATE381618T1 publication Critical patent/ATE381618T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00971403T 1999-11-04 2000-10-31 Polypeptidhormon phosphatonin ATE381618T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43418599A 1999-11-04 1999-11-04
GBGB9926424.4A GB9926424D0 (en) 1999-11-08 1999-11-08 A novel polypeptide hormone phosphatonin

Publications (1)

Publication Number Publication Date
ATE381618T1 true ATE381618T1 (de) 2008-01-15

Family

ID=26316065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00971403T ATE381618T1 (de) 1999-11-04 2000-10-31 Polypeptidhormon phosphatonin

Country Status (13)

Country Link
EP (2) EP1230369B1 (de)
JP (3) JP4424578B2 (de)
AR (1) AR027877A1 (de)
AT (1) ATE381618T1 (de)
AU (1) AU784294B2 (de)
CA (1) CA2389644C (de)
DE (1) DE60037536T2 (de)
DK (1) DK1230369T3 (de)
ES (1) ES2296649T3 (de)
MX (1) MXPA02004416A (de)
MY (1) MY127669A (de)
PT (1) PT1230369E (de)
WO (1) WO2001032878A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1130098A3 (de) * 2000-02-29 2003-09-10 Pfizer Products Inc. Säugetier Osteoreguline
WO2001072826A2 (en) * 2000-03-24 2001-10-04 Genzyme Corporation Oncogenic osteomalacia-related gene 1
AU2003221582A1 (en) * 2002-05-03 2003-11-17 Millenium Biologix Inc. Connective tissue stimulating peptides
AU2013203943C1 (en) * 2005-09-28 2016-09-01 The Regents Of The University Of California Calcium binding peptides
ES2626327T3 (es) 2009-02-06 2017-07-24 The Regents Of The University Of California Agentes enlazantes de calcio que inducen crecimiento del cabello y/o crecimiento de las uñas
US20140107321A1 (en) * 2011-05-26 2014-04-17 Dr. Reddy's Laboratories Limited Purification of antibodies
WO2022014697A1 (ja) * 2020-07-17 2022-01-20 国立大学法人広島大学 ペプチド、ペプチドの塩、医薬組成物及び生体組織石灰化抑制剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014772A1 (en) * 1993-11-12 1995-06-01 Kenichi Matsubara Gene signature
WO1999060017A2 (en) * 1998-05-18 1999-11-25 University College London Human tumour-derived polypeptide hormone phosphatonin
GB9810681D0 (en) * 1998-05-18 1998-07-15 Royal Free Hosp School Med Hormone
EP1396543A3 (de) * 1999-07-08 2004-03-31 Research Association for Biotechnology Primer zur Synthese von vollständigen cDNA Klonen und ihre Verwendung
EP1130098A3 (de) * 2000-02-29 2003-09-10 Pfizer Products Inc. Säugetier Osteoreguline
AU2001274566A1 (en) * 2000-06-21 2002-01-02 Takeda Chemical Industries Ltd. Novel protein and dna thereof

Also Published As

Publication number Publication date
JP5208021B2 (ja) 2013-06-12
ES2296649T3 (es) 2008-05-01
EP1230369A2 (de) 2002-08-14
CA2389644C (en) 2013-02-26
DK1230369T3 (da) 2008-03-31
EP1230369B1 (de) 2007-12-19
WO2001032878A3 (en) 2001-11-15
WO2001032878A2 (en) 2001-05-10
JP2013059334A (ja) 2013-04-04
PT1230369E (pt) 2008-02-15
AU1027201A (en) 2001-05-14
CA2389644A1 (en) 2001-05-10
AR027877A1 (es) 2003-04-16
MXPA02004416A (es) 2002-09-02
EP1870467A1 (de) 2007-12-26
JP2003513631A (ja) 2003-04-15
JP4424578B2 (ja) 2010-03-03
AU784294B2 (en) 2006-03-02
JP2009159975A (ja) 2009-07-23
MY127669A (en) 2006-12-29
DE60037536D1 (en) 2008-01-31
DE60037536T2 (de) 2008-12-11

Similar Documents

Publication Publication Date Title
DE69920011D1 (de) Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff
NO2010013I2 (no) Rekombinant FSH-CTP
NO982097L (no) Peptider
NO982098D0 (no) Peptider
PT926158E (pt) Hormona paratiroide cristalina
IS6040A (is) Valdekoxib efnablöndur
NO20025893L (no) Veksthormon sekretagoga
NO20020151D0 (no) Veksthormonformuleringer
GB9923177D0 (en) Novel polypeptide
DE69933647D1 (de) Rekombinante lysophosphatidsäure - phosphatase.
EP1197556A4 (de) NüTZLICHE POLYPEPTIDE
FR2791348B1 (fr) POLYPEPTIDE Npt2B
DK1230369T3 (da) Polypeptidhormon phosphatonin
DE50004258D1 (de) Transportvorrichtung
DE60020201D1 (de) Koaxialkabelherstellungsverfahren
EP1159288A4 (de) Alpha-conotoxin-peptide
EP1162269A4 (de) Polypeptid
DE50010867D1 (de) Abdeckvorrichtung
GB9923889D0 (en) Novel polypeptide
NO20013933D0 (no) Peptider
EP1179540A4 (de) Neue polypeptide
NO20012283D0 (no) Koblede peptider
EP1151100A4 (de) Tau-conotoxin peptide
GB9918680D0 (en) Polypeptide
DE50009295D1 (de) Vernetzerfreie zubereitungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1230369

Country of ref document: EP